scispace - formally typeset
C

Changlian Zhu

Researcher at University of Gothenburg

Publications -  208
Citations -  16429

Changlian Zhu is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Neuroprotection & Apoptosis. The author has an hindex of 50, co-authored 183 publications receiving 13346 citations. Previous affiliations of Changlian Zhu include Boston Children's Hospital & Karolinska Institutet.

Papers
More filters
Journal ArticleDOI

An intractable epilepsy phenotype of ASNS novel mutation in two patients with asparagine synthase deficiency.

TL;DR: Wang et al. as discussed by the authors used head Magnetic Resonance Imaging (MRI), whole exome sequencing (WES), and Liquid Chromatography-Mass Spectrometry (LC-MS) to help 2 patients with intractable epilepsy find the underlying mechanisms of disease.
Journal ArticleDOI

The role of probiotics in children with autism spectrum disorders: A study protocol for a randomised controlled trial

TL;DR: The impact of probiotics supplementation on the symptoms of Children with ASD is investigated for the purpose of evaluating the possible therapeutic effects of additives on ASD and of providing a reference for clinical treatment.
Journal ArticleDOI

Inhibition of Colony Stimulating Factor 1 Receptor Suppresses Neuroinflammation and Neonatal Hypoxic-Ischemic Brain Injury.

TL;DR: In this paper, the colony-stimulating factor 1 receptor (CSF1R) was used to suppress neuroinflammation and neonatal brain injury after acute cerebral hypoxia-ischemia in neonatal mice.
Journal ArticleDOI

The association of severe anemia, red blood cell transfusion and necrotizing enterocolitis in neonates.

TL;DR: In this paper, a 1:1 ratio case-control study was performed in very low birth weight (VLBW) infants to determine the association of severe anemia and RBC transfusion with Neonatal necrotizing enterocolitis (NEC) in neonates.
Journal ArticleDOI

Brain death affects the hepatic immunogenicity of pigs.

TL;DR: Brain death increased liver immunogenicity, which may increase the immune lesion and rejection after transplantation, and the serum TNF-alpha and IL-6, MHC-II, ICAM-1 mRNA, and MCP-1 transcripts all increased with time.